Invest with us
Our strategic vision
An innovative & unique approach
Pictor’s novel multiplex platform improves human and animal health diagnostics. Our transformative technology has the potential to be a game changer in the fight against infectious diseases in these market segments.
Raising the stakes
The Company’s transition from being solely focused on the low-cost human health diagnostic market of India, to both the high value human health market in the US and livestock diagnostic markets within New Zealand and internationally has continued.
Pictor will enter these new markets in 2022 – 2023 with highly differentiated products:
Everything you and your advisors need to know about becoming a part of Pictor's success.
Pictor has been collaborating with industry leaders from around the globe.